Sergio Padilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergio Padilla has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Félix Gutiérrez
Infectious Diseases Unit, Hospital General Universitario de Elche and Universidad Miguel Hernández de Elche , Alicante
4 shared publications - Mar Masiá
Infectious Diseases Unit, Hospital General Universitario de Elche and Universidad Miguel Hernández de Elche , Alicante
3 shared publications - Enrique Bernal
Hospital General Universitario Reina Sofía, Murcia, Spain
2 shared publications - JosÉ Manuel Ramos
Clinical Medicine Department, Miguel Hernández University of Elche, 03550 Alicante, Spain
2 shared publications Juan A. Gallego
2 shared publicationsMar Masiá
2 shared publications
Latest Publications
- 30 June 2009
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 45 (6) , 271-278
Producción española sobre tuberculosis a través del MEDLINE (1997–2006)
- 30 June 2009
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 45 (6) , 271-278
Producción española sobre tuberculosis a través del MEDLINE (1997–2006)
- 1 March 2008
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 6 (2) , 100-107
Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
To describe characteristics and prognosis of patients with suboptimal immunological response to combined antiretroviral therapy (CART). Using data from a multicenter cohort study, we selected patients who initiated CART and showed suboptimal CD4-T cell response (defined as < 50 cells/L increase) after 1 year of therapy, despite sustained virological suppression. Characteristics of those patients were compared with subjects who showed optimal immunological response. Of 650 patients with virological suppression, 108 (16.6%) showed suboptimal CD4-T cell response. Independent predictors of suboptimal response were previous injection drug use (OR, 1.85; 95% CI, 1.12-2.98) and age at CART initiation (OR, 1.04 per year increase; 95%CI, 1.01-1.06). Hepatitis C virus coinfection was not associated with impaired inmunological response. As compared with patients with optimal immunological response, those with suboptimal response had a higher mortality rate (3.22 versus 0.71 per 100 person-years; p=.001), but a similar rate of new AIDSdefining events. In patients with sustained virological suppression with CART, previous injection drug use, but not hepatitis C virus coinfection, and older age at initiation of therapy were associated with suboptimal CD4 T-cell responses. Patients with suboptimal response had a higher mortality over time, mainly due to diseases other than AIDS-defining events.
- 1 March 2008
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 6 (2) , 100-107
Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
To describe characteristics and prognosis of patients with suboptimal immunological response to combined antiretroviral therapy (CART). Using data from a multicenter cohort study, we selected patients who initiated CART and showed suboptimal CD4-T cell response (defined as < 50 cells/L increase) after 1 year of therapy, despite sustained virological suppression. Characteristics of those patients were compared with subjects who showed optimal immunological response. Of 650 patients with virological suppression, 108 (16.6%) showed suboptimal CD4-T cell response. Independent predictors of suboptimal response were previous injection drug use (OR, 1.85; 95% CI, 1.12-2.98) and age at CART initiation (OR, 1.04 per year increase; 95%CI, 1.01-1.06). Hepatitis C virus coinfection was not associated with impaired inmunological response. As compared with patients with optimal immunological response, those with suboptimal response had a higher mortality rate (3.22 versus 0.71 per 100 person-years; p=.001), but a similar rate of new AIDSdefining events. In patients with sustained virological suppression with CART, previous injection drug use, but not hepatitis C virus coinfection, and older age at initiation of therapy were associated with suboptimal CD4 T-cell responses. Patients with suboptimal response had a higher mortality over time, mainly due to diseases other than AIDS-defining events.
- 30 November 2007
- Published by Elsevier in Atherosclerosis
- Vol. 195 (1) , 167-171
The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients
- 30 November 2007
- Published by Elsevier in Atherosclerosis
- Vol. 195 (1) , 167-171
The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients
- 1 September 2007
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 5 (5) , 459-466
Ultrasonography and Anthropometry for Measuring Regional Body Fat in HIV-Infected Patients
To evaluate ultrasonography and anthropometry for the measurement of regional body fat in HIV infected patients. In a cross-sectional study, 61 patients receiving antiretroviral therapy underwent ultrasonography and anthropometry for measuring body fat at abdominal, peripheral and facial levels. Reproducibility and accuracy of the measurements at the different compartments were determined using quantitative computed tomography (CT) and clinical evaluation of lipodystrophy as reference standard. Intrabdominal and subcutaneous abdominal fat assessed by ultrasonography correlated with visceral and subcutaneous abdominal fat quantified by CT (r=0.74, P < 0.001, and r=0.84, P < 0.001, respectively). Ultrasound-determined subcutaneous fat at mid-thigh level correlated with adipose tissue area measured by CT (r = 0.84, P < 0.001). Waist-to-hip ratio (r=0.69, P < 0.001), suprailiac skinfold (r=0.78, P < 0.001) and mid-thigh skinfold thickness (r=0.83, P < 0.001) were also significantly correlated with visceral abdominal fat, subcutaneous abdominal fat, and with subcutaneous leg fat quantified by CT, respectively. Poorer correlations were found between ultrasonographic and anthropometric assessments of facial fat, and adipose tissue measured by CT (r=0.15, P=0.25, and r=0.58; P < 0.001; respectively). Reproducibility was higher for anthropometry than for ultrasonography in most body regions. The highest variability was observed for ultrasonographic assessment of facial fat (median inter-observer coefficient of variation, 32.10%). Using the clinical diagnosis of lipodystrophy as reference, the best accuracy was observed for ultrasounddetermined intrabdominal fat, waist-to-hip ratio and subcutaneous crural fat measured by ultrasonography. Ultrasonography and anthropometry are fairly accurate and reproducible methods for the evaluation of intrabdominal and peripheral fat. Its role for assessing facial fat seems to be more limited.
- 1 September 2007
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 5 (5) , 459-466
Ultrasonography and Anthropometry for Measuring Regional Body Fat in HIV-Infected Patients
To evaluate ultrasonography and anthropometry for the measurement of regional body fat in HIV infected patients. In a cross-sectional study, 61 patients receiving antiretroviral therapy underwent ultrasonography and anthropometry for measuring body fat at abdominal, peripheral and facial levels. Reproducibility and accuracy of the measurements at the different compartments were determined using quantitative computed tomography (CT) and clinical evaluation of lipodystrophy as reference standard. Intrabdominal and subcutaneous abdominal fat assessed by ultrasonography correlated with visceral and subcutaneous abdominal fat quantified by CT (r=0.74, P < 0.001, and r=0.84, P < 0.001, respectively). Ultrasound-determined subcutaneous fat at mid-thigh level correlated with adipose tissue area measured by CT (r = 0.84, P < 0.001). Waist-to-hip ratio (r=0.69, P < 0.001), suprailiac skinfold (r=0.78, P < 0.001) and mid-thigh skinfold thickness (r=0.83, P < 0.001) were also significantly correlated with visceral abdominal fat, subcutaneous abdominal fat, and with subcutaneous leg fat quantified by CT, respectively. Poorer correlations were found between ultrasonographic and anthropometric assessments of facial fat, and adipose tissue measured by CT (r=0.15, P=0.25, and r=0.58; P < 0.001; respectively). Reproducibility was higher for anthropometry than for ultrasonography in most body regions. The highest variability was observed for ultrasonographic assessment of facial fat (median inter-observer coefficient of variation, 32.10%). Using the clinical diagnosis of lipodystrophy as reference, the best accuracy was observed for ultrasounddetermined intrabdominal fat, waist-to-hip ratio and subcutaneous crural fat measured by ultrasonography. Ultrasonography and anthropometry are fairly accurate and reproducible methods for the evaluation of intrabdominal and peripheral fat. Its role for assessing facial fat seems to be more limited.
- Open Access
- 15 December 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (12) , 1848-1851
Single-Slice Computed Tomography and Anthropometric Skinfold Analysis for Evaluation of Facial Lipoatrophy in HIV-Infected Patients
We assessed the value of computed tomography (CT) and anthropometric skinfold analysis for evaluating subcutaneous facial fat in human immunodeficiency virus-infected patients. Patients with facial lipoatrophy had smaller areas of facial adipose tissue, lower ratios of adipose tissue area to total tissue area of the face, and lower malar skinfold values, compared with patients without facial wasting. CT may be a useful technique to diagnose and monitor facial lipoatrophy.
- 15 December 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (12) , 1848-1851
Open AccessSingle-Slice Computed Tomography and Anthropometric Skinfold Analysis for Evaluation of Facial Lipoatrophy in HIV-Infected Patients
We assessed the value of computed tomography (CT) and anthropometric skinfold analysis for evaluating subcutaneous facial fat in human immunodeficiency virus-infected patients. Patients with facial lipoatrophy had smaller areas of facial adipose tissue, lower ratios of adipose tissue area to total tissue area of the face, and lower malar skinfold values, compared with patients without facial wasting. CT may be a useful technique to diagnose and monitor facial lipoatrophy.